• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses

tetano

Editor, Senior Moderator
Nat Commun


. 2021 Jun 8;12(1):3431.
doi: 10.1038/s41467-021-23779-5.
A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses


Alberto A Amarilla[SUP] #[/SUP][SUP] 1 [/SUP], Julian D J Sng[SUP] #[/SUP][SUP] 1 [/SUP], Rhys Parry[SUP] #[/SUP][SUP] 1 [/SUP], Joshua M Deerain[SUP] #[/SUP][SUP] 2 [/SUP], James R Potter[SUP] #[/SUP][SUP] 1 [/SUP], Yin Xiang Setoh[SUP] #[/SUP][SUP] 1 3 [/SUP], Daniel J Rawle[SUP] 4 [/SUP], Thuy T Le[SUP] 4 [/SUP], Naphak Modhiran[SUP] 1 [/SUP], Xiaohui Wang[SUP] 1 [/SUP], Nias Y G Peng[SUP] 1 [/SUP], Francisco J Torres[SUP] 1 [/SUP], Alyssa Pyke[SUP] 5 [/SUP], Jessica J Harrison[SUP] 1 [/SUP], Morgan E Freney[SUP] 1 [/SUP], Benjamin Liang[SUP] 1 [/SUP], Christopher L D McMillan[SUP] 1 [/SUP], Stacey T M Cheung[SUP] 1 [/SUP], Darwin J Da Costa Guevara[SUP] 1 [/SUP], Joshua M Hardy[SUP] 6 [/SUP], Mark Bettington[SUP] 7 [/SUP], David A Muller[SUP] 1 [/SUP], Fasséli Coulibaly[SUP] 6 [/SUP], Frederick Moore[SUP] 5 [/SUP], Roy A Hall[SUP] 1 8 [/SUP], Paul R Young[SUP] 1 8 [/SUP], Jason M Mackenzie[SUP] 9 [/SUP], Jody Hobson-Peters[SUP] 10 11 [/SUP], Andreas Suhrbier[SUP] 12 13 [/SUP], Daniel Watterson[SUP] 14 15 [/SUP], Alexander A Khromykh[SUP] 16 17 [/SUP]



Affiliations

Abstract

The current COVID-19 pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We demonstrate that despite the large size of the viral RNA genome (~30 kb), infectious full-length cDNA is readily assembled in vitro by a circular polymerase extension reaction (CPER) methodology without the need for technically demanding intermediate steps. Overlapping cDNA fragments are generated from viral RNA and assembled together with a linker fragment containing CMV promoter into a circular full-length viral cDNA in a single reaction. Transfection of the circular cDNA into mammalian cells results in the recovery of infectious SARS-CoV-2 virus that exhibits properties comparable to the parental virus in vitro and in vivo. CPER is also used to generate insect-specific Casuarina virus with ~20 kb genome and the human pathogens Ross River virus (Alphavirus) and Norovirus (Calicivirus), with the latter from a clinical sample. Additionally, reporter and mutant viruses are generated and employed to study virus replication and virus-receptor interactions.
 
Back
Top Bottom